You are here

myelodysplastic syndrome

Patient death spurs trial halt for Magenta Therapeutics

Patient death spurs trial halt for Magenta Therapeutics

Endpoints

Magenta Therapeutics

clinical trials

myelodysplastic syndrome

Flag link:

Why The Magenta Therapeutics (MGTA) Stock Plummeted Over 50%

Why The Magenta Therapeutics (MGTA) Stock Plummeted Over 50%

Pulse 2.0

Magenta Therapeutics

clinical trials

myelodysplastic syndrome

Flag link:

With positive trial results, Bristol Myers looks to widen use of blood disease drug

With positive trial results, Bristol Myers looks to widen use of blood disease drug

BioPharma Dive

Bristol Myers Squibb

myelodysplastic syndrome

Flag link:

I-Mab reports positive data from Phase II myelodysplastic syndrome trial

I-Mab reports positive data from Phase II myelodysplastic syndrome trial

Clinical Trials Arena

clinical trials

myelodysplastic syndrome

Flag link:

EHA 2021 – Curis’s renaissance continues

EHA 2021 – Curis’s renaissance continues

EP Vantage

myelodysplastic syndrome

acute myelogenous leukemia

clinical trials

Flag link:

Onconova reports PhIII flop, putting high-risk MDS program on the chopping block

Onconova reports PhIII flop, putting high-risk MDS program on the chopping block

Endpoints

clinical trials

myelodysplastic syndrome

Flag link:

Takeda gets FDA breakthrough therapy status for pevonedistat to treat higher-risk HR-MDS

Takeda gets FDA breakthrough therapy status for pevonedistat to treat higher-risk HR-MDS

Pharmaceutical Business Review

Takeda Pharmaceuticals

breakthrough status

myelodysplastic syndrome

Flag link:

This Cancer Drug Is Driving Forty Seven's Stock Higher

This Cancer Drug Is Driving Forty Seven's Stock Higher

Motley Fool

clinical trials

myelodysplastic syndrome

Flag link:

Astex Pharma and Otsuka’s Cancer Trial Meets Primary Endpoints

Astex Pharma and Otsuka’s Cancer Trial Meets Primary Endpoints

BioSpace

clinical trials

myelodysplastic syndrome

Flag link:

Celgene and Acceleron Submit BLA for Luspatercept

Celgene and Acceleron Submit BLA for Luspatercept

CP Wire

myelodysplastic syndrome

beta thalassemia

Flag link:

CytoSen Therapeutics Receives Favorable Response to Pre-IND Meeting Package for Phase 2 Study in Acute Myeloid Leukemia

CytoSen Therapeutics Receives Favorable Response to Pre-IND Meeting Package for Phase 2 Study in Acute Myeloid Leukemia

CP Wire

acute myeloid leukemia

myelodysplastic syndrome

Flag link:

CytoSen Therapeutics Receives Favorable Response to Pre-IND Meeting Package for Phase 2 Study in Acute Myeloid Leukemia

acute myeloid leukemia

myelodysplastic syndrome

Flag link:

Acceleron blood disease drug hits goal in pivotal clinical trial

Acceleron blood disease drug hits goal in pivotal clinical trial

Stat

clinical trials

myelodysplastic syndrome

Flag link:

Aptevo Therapeutics Submits IND for APVO436 For Acute Myeloid Leukemia and Myelodysplastic Syndrome

Aptevo Therapeutics Submits IND for APVO436 For Acute Myeloid Leukemia and Myelodysplastic Syndrome

CP Wire

myelodysplastic syndrome

Flag link:

Aptevo Therapeutics Submits IND for APVO436 For Acute Myeloid Leukemia and Myelodysplastic Syndrome

acute myeloid leukemia

myelodysplastic syndrome

Flag link:

Geron Collaborates with J&J for Imetelstat

Geron Collaborates with J&J for Imetelstat

Yahoo/Zacks

acute myelogenous leukemia

myelodysplastic syndrome

Flag link:

Sunesis says encouraged by trial of Qinprezo

Sunesis says encouraged by trial of Qinprezo

The Fly on the Wall

acute myeloid leukemia

myelodysplastic syndrome

Flag link:

Can This Celgene Drug Defy the Patent Cliff?

Can This Celgene Drug Defy the Patent Cliff?

Motley Fool

myelodysplastic syndrome

Flag link:

Still Revving Up With Revlimid

Still Revving Up With Revlimid

Motley Fool

myelodysplastic syndrome

Multiple Myeloma

Flag link:

What Is So Exciting About MEI Pharma?

What Is So Exciting About MEI Pharma?

Seeking Alpha

myelodysplastic syndrome

Flag link:

Pages